Likewise, serum NGAL levels were significantly higher in the COPD‐S group than in the COPD‐NS group (11.9 versus 7.1 ng/ml, respectively; P = 0.001; Fig. 1C). This evidence concerns the gene LCN2 and chronic obstructive pulmonary disease.